„Going beyond” Jak lekarze weterynarii przekraczają granice
„Going beyond” Jak lekarze weterynarii przekraczają granice
Szukaj
Informacja o ochronie danych w ramach nadzoru nad bezpieczeństwem farmakoterapii w odniesieniu do produktów zdrowotnych pochodzenia zwierzęcego
Informacja o ochronie danych dla klientów, partnerów, odwiedzających i innych osób, których dane dotyczą
Informacja o ochronie danych dla przedstawicieli zawodów związanych ze zdrowiem zwierząt
Informacja o ochronie danych dla przedstawicieli zawodów medycznych
Informacja o ochronie danych w przypadku dochodzeń medycznych
Ochrona danych osobowych
Ochrona danych osobowych
World Recycling Day: Closing the Loop
Transitioning the economy from a linear to a circular approach herculean task – but also an innovation that carries huge potential
Labor & Human Rights
Suppliers shall support and respect the protection of internationally proclaimed human rights.
Bigger role in ensuring food security
As the world population is projected to reach 9.8 billion in 2050, animal health becomes fundamental to ensure both animal well-being and global protein supply.
Our Approach
We are driven by the desire to improve human and animal health -– now and in the future. Therefore, we have developed our framework: Sustainable Development – For Generations.
BI Access to Healthcare Strategy_Availability
Boehringer Ingelheim aspires to be a leader in ensuring improved access by delivering More Health to humans, animals and communities around the world. Read more about our holistic approach, based on partnerships and local empowerment.
Our Partnering Culture
We embrace the power of partnerships and alliances to find even more breakthrough therapies that change lives.
Our Partners_ViraTherapeutics
Lisa Egerer, COO and Patrik Erlman, Head of Research at ViraTherapeutics talk about their partnering journey with Boehringer Ingelheim.
Advancing regenerative medicine
Strategic partnerships play a key role in helping the company accelerate the next generation of breakthroughs.
Retinal health
We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in Retinal Health.
Historia (1885-1948): Nowatorskie początki
Historia Boehringer Ingelheim od rozpoczęcia działalności w 1885 roku do 1948 roku, z kamieniami milowymi i ważnymi produktami
Where to meet us
Find all our contact information here as well as information on where you can meet us virtually or in person. You can also find out how to submit your opportunity to our BD&L team.
Big hearts united to help animals in Ukraine
Veterinaries volunteer at the Polish-Ukrainian border to help welcome Refugees and their animals. Refugees don’t rest until their animals are safe.
SIRPα Cancer Immunology Research
Boehringer Ingelheim scientists are investigating a new target in the innate immune system - signal-regulating protein alpha or SIRPα.
Be green Japan
Boehringer Ingelheim's Yamagata site is gradually switching to a more sustainable energy supply.
Patient Safety
Patient Safety
Covid19 relief program Ghana Cowtribe parasiticides
Boehringer Ingelheim and Cowtribe are kicking off a vital relief initiative in Ghana.
Mechanistic Modeling in Biotherapeutic Drug Development
Mechanistic modeling is revolutionizing biotherapeutic drug development with the goal of getting new medicines to patients faster, more reliably and more cost-effectively.
Our Commitment
We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals.